EODData

NASDAQ, XENE: Xenon Pharmaceuticals Inc

01 Oct 26 13:30
LAST:

39.48

CHANGE:
 2.29
OPEN:
37.19
HIGH:
39.92
ASK:
3.05
VOLUME:
1.63M
CHG(%):
6.14
PREV:
37.19
LOW:
37.15
BID:
2.40
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
01 Oct 2637.1939.9237.1539.481.63M
30 Sep 2637.3837.5336.7137.192.47M
29 Sep 2636.3037.4336.2037.252.75M
28 Sep 2636.8536.8536.1036.722.52M
25 Sep 2638.1038.2636.4836.942.43M
24 Sep 2636.5038.3436.0738.063.11M
23 Sep 2639.5139.5136.0736.563.17M
22 Sep 2639.7639.7637.9739.092.35M
21 Sep 2640.0040.2638.6038.994.05M
18 Sep 2644.0244.8539.0839.7517.95M

PROFILE

Name:Xenon Pharmaceuticals Inc
About:Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Sector:Healthcare
Industry:Biotechnology
Address:200-3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8
Website:https://www.xenon-pharma.com
CUSIP:98420N105
CIK:0001582313
ISIN:CA98420N1050
FIGI:BBG0073DM784

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-13.66 
Forward P/E:-12.29 
PEG Ratio:-0.32 
Price to Sales:422.75 
Price to Book:8.47 
Operating Margin:-42.42 
Return on Assets:-0.26 
Return on Equity:-0.38 
EPS Ratio:-4.70 
Revenue:7.5M 
Shares:96.67M 
Market Cap:3.816B 

TECHNICAL INDICATORS

MA5:37.485.3%
MA10:37.983.9%
MA20:48.2322.2%
MA50:56.9944.4%
MA100:57.4245.5%
MA200:53.1234.6%
STO9:73.65
STO14:11.83 
RSI14:17.68 
WPR14:-87.40 
MTM14:-18.91
ROC14:-0.32 
ATR:2.96 
Week High:39.921.1%
Week Low:36.079.4%
Month High:61.7556.4%
Month Low:36.0734.6%
Year High:72.6684.1%
Year Low:36.079.4%